Tag: Junshi Biosciences

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Junshi Biosciences

CHOICE-01 Phase III Study of Toripalimab at the Interim Analysis Met Pre-Specified Primary ...

Added to Collection on: 2020-12-14 00:00:00

Tags for this article:

Drugs
Cancer treatments
Clinical medicine
Lung cancer
Breakthrough therapy
Orphan drugs
Non-small-cell lung carcinoma
Clinical endpoint
Nasopharyngeal carcinoma
Atezolizumab
Ramucirumab
Shanghai
Junshi Biosciences
China

Click the tags to see associated articles and topics

View Article Details
Junshi Biosciences Announces Inclusion of Toripalimab in The China National Reimbursement ...

Added to Collection on: 2020-12-29 01:18:45

Tags for this article:

Clinical medicine
Medicine
Health care
Cancer immunotherapy
Cancer
Melanoma
Breakthrough therapy
Programmed cell death protein 1
Immunotherapy
PD-1 and PD-L1 inhibitors
Atezolizumab
Shanghai
Junshi Biosciences
China

Click the tags to see associated articles and topics

View Article Details
Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi ...

Added to Collection on: 2021-02-01 10:30:00

Tags for this article:

Drugs
Life Sciences
Health care
Biotechnology
Specialty drugs
Monoclonal antibodies
Orphan drugs
Cancer immunotherapy
Genentech
Biosimilar
Adalimumab
Bevacizumab
Coherus Biosciences Inc.
Shanghai Junshi Biosciences
Junshi Biosciences
United States
Canada
China

Click the tags to see associated articles and topics

View Article Details
Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 ...

Added to Collection on: 2021-02-01 12:45:00

Tags for this article:

Drugs
Clinical medicine
Cancer treatments
Orphan drugs
Breakthrough therapy
Lung cancer
Angiogenesis inhibitors
Cancer immunotherapy
Melanoma
Non-small-cell lung carcinoma
Head and neck cancer
Bevacizumab
Shanghai
Coherus Biosciences Inc.
Junshi Biosciences
United States
Canada
China

Click the tags to see associated articles and topics

View Article Details
Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 ...

Added to Collection on: 2021-02-03 15:45:00

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Antineoplastic drugs
Bristol-Myers Squibb
Breakthrough therapy
Cancer immunotherapy
Ipilimumab
Nivolumab
Programmed cell death protein 1
Melanoma
Immunotherapy
Eucure Biopharma
Junshi Biosciences
Beijing

Click the tags to see associated articles and topics

View Article Details
Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for ...

Added to Collection on: 2021-03-03 17:03:45

Tags for this article:

Drugs
Clinical medicine
Health care
Orphan drugs
Monoclonal antibodies
Breakthrough therapy
Bevacizumab
Bamlanivimab/etesevimab
Cancer immunotherapy
Nasopharyngeal carcinoma
Nivolumab
Pembrolizumab
Shanghai
shanghai junshi biosciences co., ltd.
Coherus Biosciences Inc.
Junshi Biosciences
United States
Canada
China

Click the tags to see associated articles and topics

View Article Details
Eucure Biopharma Announces Breakthrough Phase I Results for Anti-CTLA-4 Therapy in ...

Added to Collection on: 2021-03-22 14:26:15

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Bristol-Myers Squibb
Breakthrough therapy
Immune system
Antineoplastic drugs
Cancer immunotherapy
Ipilimumab
Programmed cell death protein 1
Melanoma
Treatment of cancer
Eucure Biopharma
Junshi Biosciences
Beijing
Australia
China

Click the tags to see associated articles and topics

View Article Details
Lonza to make Junshi Biosciences antibody at China facility

Added to Collection on: 2021-04-14 12:22:30

Tags for this article:

Life Sciences
Medical specialties
Biology
Biotechnology
Immunology
Glycoproteins
Immune system
Antibody
Biopharmaceutical
Bamlanivimab/etesevimab
Monoclonal antibody
Xceed
China
Junshi Biosciences

Click the tags to see associated articles and topics

View Article Details
Toripalimab Plus Chemotherapy as First-Line Treatment for Advanced Esophageal Cancer ...

Added to Collection on: 2021-04-22 12:47:45

Tags for this article:

Clinical medicine
Drugs
Cancer
Orphan drugs
Lung cancer
Breakthrough therapy
Carcinoma
Infectious causes of cancer
Esophageal cancer
Squamous cell carcinoma
Transitional cell carcinoma
Nasopharyngeal carcinoma
Shanghai
Junshi Biosciences
China

Click the tags to see associated articles and topics

View Article Details
Book a Demo